SCHEMBL7316129

SCHEMBL7316129

Cn1cc([S+](C)[O-])c(=O)c2ccc(Br)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.35
CDK2 P24941 3/20 0.34
CDK4 P11802 2/20 0.34
CCND1 P24385 2/20 0.34
CCNE2 O96020 1/20 0.34
CCNE1 P24864 1/20 0.34
EGLN1 Q9GZT9 2/20 0.32
CDK5 Q00535 2/20 0.32
PDGFRA P16234 1/20 0.32
TYRO3 Q06418 1/20 0.32
SCN9A Q15858 1/20 0.32
CAMK2D Q13557 1/20 0.32
MAPK8 P45983 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
CHEK1 O14757 1/20 0.31
CCNT1 O60563 1/20 0.30
CDK1 P06493 1/20 0.30
CCNB1 P14635 1/20 0.30
CCND3 P30281 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7317623 0.84 TP53 (0.38) GSK3BCDK2ALDH1A1
SCHEMBL10943341 0.82 NTRK1 (0.40) GSK3BCDK2CDK4CCND1CDK1
Flosequinan SCHEMBL5441172 0.82 ATM (0.47) GSK3BCDK2CDK4CCND1CCNE2
Flosequinan SCHEMBL5442796 0.82 ATM (0.47) GSK3BCDK2CDK4CCND1CCNE2
Flosequinan SCHEMBL122877 0.82 ATM (0.47) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL11406579 0.81 HTR1D (0.39) ALDH1A1
Flosequinan SCHEMBL6535622 0.81 ATM (0.46) GSK3BCDK2CDK4CCND1CCNE2
SCHEMBL11401644 0.81 KDM4E (0.31) CNR1CNR2ALDH1A1
SCHEMBL11401796 0.80 ALDH1A1 (0.52) GSK3BALDH1A1
SCHEMBL11398354 0.80 SCN9A (0.33) GSK3BCDK5TYRO3SCN9AMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4552884-A Method of treating heart disease THE BOOTS COMPANY PLC (GB) 1985-11-12 US disclosed
EP-0149519-A2 Use of quinolones for the manufacture of a composition for the treatment of heart failure. The Boots Company PLC (GB) 1985-07-24 EP disclosed
US-4302460-A 4-Quinolinones having antihypertensive activity THE BOOTS COMPANY LIMITED (GB) 1981-11-24 US disclosed